RNTX
Rein Therapeutics
RNTX
RNTX
20 hedge funds and large institutions have $3.25M invested in Rein Therapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.25% less ownership
Funds ownership: 23.03% → 21.78% (-1.3%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$116K | |
| 2 | +$50.5K | |
| 3 | +$48.1K | |
| 4 |
Renaissance Technologies
New York
|
+$27.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.54K |
Top Sellers
| 1 | -$30.4K | |
| 2 | -$29K | |
| 3 | -$6.96K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$2.13K |